Group items tagged

"This report provides detailed historical analysis of global market for Healthcare Plastics from 2013-2018, and provides extensive market forecasts from 2018-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Healthcare Plastics market. Market segment by Region/Country including: * North America (United States, Canada and Mexico) * Europe (Germany, UK, France, Italy, Russia and Spain etc.) * Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.) * South America Brazil, Argentina, Colombia and Chile etc.) * Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)"

Webinar on commonly cited accreditation surveyor citations for facility operations, and what could be done to avoid these citations by administrators.

"The global lanolin market size is projected to reach USD 334 million by 2025 expanding at a CAGR of 6.0%. Rising demand from the personal care and cosmetics market coupled with increasing application in the manufacturing sector is expected to boost the market growth. Lanolin is derived as a natural, waxy secretion from the sebaceous glands of sheep and other mammals that produce wool. It is widely utilized across numerous personal care products, such as cosmetics, baby care, hair & skin care, women's hygiene, and sanitation products. The product contains cholesterol, lanolin ester, alcohols, and acids that are ideal for application in cosmetics owing to highly moisturizing, lubricating, and emollient properties. Moreover, increasing demand from the pharmaceuticals and healthcare sectors owing to a rising preference for non-toxic and chemical-free products will drive the market growth further. The support of local governments through funds and tax exemption for the development of lanolin associated ancillary industries is expected to complement the growth in this sector. Asia Pacific led the global market owing to a growing animal husbandry industry. In addition, presence of a large number of personal care manufacturers in this region is expected to play a major role in driving the market."

The global breast cancer drug market size is expected to reach USD 38.4 billion by 2025. It is projected to expand at a CAGR of 10.7% during the forecast period. Early detection, increase in awareness, and incidence of breast cancer are some of the key trends stoking market growth. Global breast cancer drugs market is expected to grow lucratively as many players focus majorly on R&D of innovative treatments. They engage in extensive research to develop novel drugs for the treatment of the disease to gain a higher market share. There exists a growing pressure and need for novel therapies and treatment due to rapidly accelerating prevalence of diseases. The strong pipeline is expected to provide new and effective treatment options and improved outcomes than existing therapies. With advancements in drug delivery systems, various target specific therapies have been customized and designed as a carrier to infuse the therapeutic agent to the target site. Carriers for inducing target therapy include modified anticancer agent's specific to molecular-recognition-element, anticancer peptides, and nanoparticle-based anticancer drugs. For instance, HER2/neu protein is usually given in combination with other anti-cancer drugs in targeted therapy. Get Free Sample Copy of this Report at at: https://www.radiantinsights.com/research/breast-cancer-drugs-market/request-sample F. Hoffman-La Roche Ltd leads the breast cancer drugs market with Herceptin, Perjeta, and Kadcyla. However, rapid advancements in biosimilars with a goal to offer cost effective alternatives to patients is anticipated to put pressure on this space. For instance, in December 2017, the Food and Drug Administration (FDA) approved the first biosimilar of trastuzumab for HER2+ breast cancer. Further key findings from the report suggest: * HER2 inhibitors is expected to be the most preferred drug class segment over the forecast period, owing to their high specificity as they are subclass of target therapy *

"The global breathable films market size is expected to reach USD 24.3 billion by 2025 expanding at a CAGR of 6.0% over the forecast period. It is estimated to be driven by increasing construction spending in Asia Pacific coupled with growth of the overall packaging market. Breathable films are widely used across key end-use industries, such as hygiene, healthcare, building and construction, industrial apparel, packaging, and sports apparel. Asia Pacific is the fastest-growing region for various end-use industries on account of rising disposable income level of consumers, mainly in emerging economies, such as China and India."